Title: Frankly Speaking About Lung Cancer
1(No Transcript)
2Frankly Speaking About Lung Cancer
- The Wellness Community provides a free program of
emotional support, education and hope for people
with cancer and their loved ones.
3Frankly Speaking About Lung Cancer
- The Wellness Community
- Patient Active Concept
- Cancer patients who participate in their fight
for recovery along with their healthcare team
will improve the quality of their lives and may
enhance the possibility of recovery.
4Frankly Speaking About Lung Cancer
- The Wellness Community
- national non-profit organization
- 21 locations nationwide 2 international
- over 12,000 support group sessions
- 138,000 visits each year
- Research, publications
- The Virtual Wellness Community
5The Wellness Community Programs
- Nutritional education
- Stress reduction programs (Tai Chi, Yoga, etc.)
- Exercise programs
- Childrens programs
- Resource library
- Social activities
- Weekly patient support groups
- Weekly family support groups
- Diagnosis specific networking groups
- Bereavement groups
- Educational programs
All programs are free of charge!
6Frankly Speaking About Lung Cancer
- What You Need to
- Know About Lung Cancer
- Its Treatment
-
7Frankly Speaking About Lung Cancer
- Powerful facts
- 177,000 cases annually
- Lung cancer is the 1 cause of cancer-related
deaths by far in the U.S. - more than breast, prostate, and colon cancer
combined.
8Frankly Speaking About Lung Cancer
- Risk Factors
- Smoking (90 of all cases)
- Second-hand smoke (25 of non-smoker cases)
- Occupational/environmental
-
-
9Frankly Speaking About Lung Cancer
- Non-Small Cell Lung Cancer (NSCLC)
- Comprises 85 of all lung cancers
- Types of NSCLC
- Adenocarcinoma (most common)
- Squamous cell
- Bronchoalveolar Carcinoma
- Large Cell Carcinoma
- Adenosquamous
10Frankly Speaking About Lung Cancer
- Small Cell Lung Cancer (SCLC)
- Comprises 15-20 of all lung cancers
- Spreads more aggressively than NSCLC
- Is more responsive to chemotherapy
- Frequently found in smokers or former smokers
11Frankly Speaking About Lung Cancer
- Stages of Non-Small Cell Lung Cancer
- Stage I confined to lung tissue alone
- Stage II lung tissue and lymph nodes in lung
- Stage III lung tissue and lymph nodes outside
of the lung - Stage IV distant spread (liver, adrenal
glands, bone, brain, other sites)
12Frankly Speaking About Lung Cancer
-
- LUNG CANCER STAGING (TNM)
- T Primary tumor size (T1-T4)
- N Lymph node involvement (N1-N3)
- M Distant metastasis (M0-M1)
-
13Frankly Speaking About Lung Cancer
- Treatment of Stage I NSCLC
- Evaluate for surgery
- Surgery alone is the standard of care
- Pathologic stage I 67 cure
- Clinical trials are evaluating the value of
adjuvant (after surgery) therapy
14Frankly Speaking About Lung Cancer
- Treatment of Stage II NSCLC
- Evaluate for type of surgery
- Surgery alone is the standard of care
- Pathologic stage II 40-50 cure
- Clinical trials are evaluating the value of
adjuvant (after surgery) therapy
15Frankly Speaking About Lung Cancer
- Theoretical Advantages of Combining Different
Types of Cancer Therapies - Chemotherapy
- ?Controls micro-metastases that may be
responsible for systemic recurrence after
successful surgery - ?Acts synergistically with XRT to downstage
NSCLC and make tumor-free margin surgery more
likely - Radiation Therapy
- ? Sterilizes surgical margins making local
recurrence less likely -
16Frankly Speaking About Lung Cancer
- Summary Treatment Stage I II NSCLC
- Surgery is the standard of care
- Neoadjuvant (given before surgery) therapy is
promising - Adjuvant (given after surgery) chemotherapy or
radiation therapy show no improvement
17Frankly Speaking About Lung Cancer
- Stage III Non-Small Cell Lung Cancer
- 2 types Stage IIIA and Stage IIIB
- Radiation alone was the standard care until
1990s - Chemotherapy radiation is the new standard
based on results of clinical trials - Newer radiation techniques minimize side effects
of treatment -
18Frankly Speaking About Lung Cancer
- Treatment of Stage III NSCLC
- Chemo radiation standard of care
- Role of surgery is undefined
- Unanswered questions
- -Which chemo is best? How does one decide?
- -When how should chemotherapy be given?
- -When how should radiation be given?
19Frankly Speaking About Lung Cancer
- Stage III A Non-Small Cell Lung Cancer
- Bulky vs. minimal disease
- Chemotherapy radiation
- Commonly used chemotherapy drugs
- Platinum-based
- Non-platinum based
- Role of surgery undefined
20Frankly Speaking About Lung Cancer
- Stage III B Non-Small Cell Lung Cancer
- Pleural effusion affects treatment plan
- Chemotherapy radiation or radiation alone
- Commonly used chemotherapy drugs
- Platinum-based
- Non-platinum based
-
21Frankly Speaking About Lung Cancer
- Treatment of Stage IIIB-IV NSCLC
- Reduce Chemotherapy Toxicity
- Recent study Combination of 2 drugs provide same
benefit as 3, but with fewer side effects - Less nausea/vomiting
- Less hair loss
- Less nerve damage
- Lower risk of infection
- Gemcitabine vinorelbine slightly less toxicity
but equivalent response - (Cancer, Vol. 95, No. 6, 2002)
22Frankly Speaking About Lung Cancer
- Stage IV NSCLC
-
- NCI Recommended First-Line Chemotherapy
- gemcitabine cisplatin
- paclitaxel carboplatin or cisplatin
- vinorelbine cisplatin
- docetaxel cisplatin
- Other drug combinations
-
-
23Frankly Speaking About Lung Cancer
- Treatment of Recurrent NSCLC
- Challenges of decision-making
- General health status of the patient
- Several treatment options with equivalent results
but widely varying side effects - Balancing quality of life with side effects
- Patients goals and wishes
-
24Frankly Speaking About Lung Cancer
- Treatment of Recurrent NSCLC
- NCI Recommended treatment options
- Chemotherapy
- vinorelbine cisplatin
- paclitaxel cisplatin or carboplatin
- gemcitabine cisplatin
- docetaxel cisplatin
- Other drug combinations
- Palliative radiation therapy to relieve symptoms
-
25Frankly Speaking About Lung Cancer
- Treatment of Small Cell Lung Cancer
- Limited stage chemo xrt standard of care
- etoposide cisplatin radiation
- cisplatin irinotecan
- Extensive stage first-line chemotherapy
- etoposide (VP-16) cisplatin (or carboplatin)
radiation - cisplatin irinotecan
- CAV, CAE in clinical trials
26Frankly Speaking About Lung Cancer
- Treatment of Recurrent Small Cell Lung Cancer
- Possible Chemotherapy Agents
- topotecan (Hycamtin) only FDA-approved drug for
recurrent disease - oral etoposide (VP-16)
- paclitaxel (Taxol)
- irinotecan/CPT-11 (Camptosar)
- CAV
- others in clinical trials
- Palliative radiation to relieve symptoms
27Frankly Speaking About Lung Cancer
- Newer Strategies Targeted Therapy
- Chemotherapy targets general features of cells,
including both cancer cells and normal cells - Normal cells usually recover, while cancer cells
may not - However, chemotherapy is associated with side
effects
28Frankly Speaking About Lung Cancer
Examples of Lung Cancer Targeted Therapy in
Development
- Epidermal Growth Factor Receptors
- Angiogenesis
- Antisense
- Protein Kinase C
- C-kit
- PDGF-r
- Cox-2
- Ras inhibitors
- Raf inhibitors
- Map kinase
- Others
29Frankly Speaking About Lung Cancer
- Epidermal Growth Factor Receptors
- Iressa (AstraZeneca)
- Tarceva (Genentech)
- Erbitux (Imclone, BMS)
- Many others in development
30Frankly Speaking About Lung Cancer
- Angiogenesis Inhibitors
- Angioblood vessel, Genesisformation or
beginning - Many agents being tested to inhibit this process
- Anti-VEGF
- Thalidomide
- Angiostatin/Endostatin
- Anti-VEGF tyrosine kinase inhibitors
- Others
31Frankly Speaking About Lung Cancer
- Antisense Drugs
- Affinitac (Lilly)
- Antisense drug to protein kinase C
- Phase II studies completed combining with
chemotherapy - Evaluating effectiveness in recurrent lung cancer
- Phase III trials underway comparing chemotherapy
drug -
32Frankly Speaking About Lung Cancer
- What You Need to
- Know About Lung Cancer
- Its Treatment
- Questions and Discussion
33Frankly Speaking About Lung Cancer
34Frankly Speaking About Lung Cancer
- Issues to Discuss With Your Doctor When Making
Decisions About Lung Cancer Treatment - A Patient Active Approach
35Frankly Speaking About Lung Cancer
- Making decisions about cancer treatment is a
complex and sometimes overwhelming experience. - You have choices. But you need to be informed
you need to evaluate many aspects of your care.
36Frankly Speaking About Lung Cancer
- What is the goal of my cancer therapy?
- Is it prolongation of life?
- Is to control symptoms?
- Is it palliation?
37Frankly Speaking About Lung Cancer
- What is a clinical trial and would one be a
reasonable treatment option for me? - What are the risks and benefits?
38Frankly Speaking About Lung Cancer
- Clinical Trial Definitions
- Phase I-new drug/treatment well-tested in the lab
now testing toxicity in people - Phase II-new drug/treatment has given good
preliminary results-test feasibility - Phase III-compares new drug/treatment vs standard
of care -
39Frankly Speaking About Lung Cancer
- What are the risks of treatment?
- What are the risks of no treatment?
- Should I seek a second opinion?
40Frankly Speaking About Lung Cancer
- Are there some treatments that have equal
benefit, but fewer or different - side effects?
- Can we discuss which side effects I would be most
concerned about having or preventing?
41Frankly Speaking About Lung Cancer
- How do we balance my quality of life with my need
for effective treatment? - How will we know that the treatment is working?
- What can I expect to happen to me as the cancer
progresses?
42Frankly Speaking About Lung Cancer
- Can I continue to work or maintain my other daily
activities during treatment? - If I have pain, what should I do?
- Nausea vomiting?
- Fatigue?
- Risk of infection?
-
43Frankly Speaking About Lung Cancer
- Why do some people who smoke get lung cancer
while others dont? - Why did I get lung cancer if I never smoked?
44Frankly Speaking About Lung Cancer
- What kind of supportive resources are available
to me and my family? - What can I expect from an emotional perspective?
-
45Frankly Speaking About Lung Cancer
- Questions to Ask Yourself
- What can I do to be a stronger partner with my
physician health care team? - What is my goal of therapy and have I expressed
that to my physician?
46Frankly Speaking About Lung Cancer
- Am I ready and willing to participate fully and
actively in my treatment plan? - Do I know what the potential side effects of
therapy are and how best to prevent or manage
them? - Have I communicated with my physician what
quality of life means to me?
47Frankly Speaking About Lung Cancer
- How will I (and my family) address the emotional
issues of living with lung cancer? - Is a support group right for me (and/or my
family)?
48Frankly Speaking About Lung Cancer
- Making decisions about lung cancer and its
treatment is never easy. - By being informed partnering with your
physician health care team, you can improve the
quality of your life and may enhance the
possibility of your recovery.
49Frankly Speaking About Lung Cancer
- Making Decisions About Lung Cancer Treatment
- Questions and Discussion